Endocrine Society GUIDELINES Bundle (free trial)

Hirsutism

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1140154

Contents of this Issue

Navigation

Page 2 of 9

➤ Endocrine Society (ES) suggests testing for elevated androgen levels in all women with an abnormal hirsutism score. (2|⊕⊕ ) ➤ In those cases where serum total testosterone levels are normal, if sexual hair growth is moderate/severe or sexual hair growth is mild but there is clinical evidence of a hyperandrogenic endocrine disorder (such as menstrual disturbance or progression in spite of therapy), ES suggests measuring an early morning serum total and free testosterone by a reliable specialty assay. (2|⊕⊕ ) ➤ ES suggests screening hyperandrogenemic women for nonclassical congenital adrenal hyperplasia (NCCAH) due to 21-hydroxylase deficiency by measuring early morning 17-hydroxyprogesterone levels in the follicular phase or on a random day for those with amenorrhea or infrequent menses. (2|⊕⊕ ) • In hirsute patients with a high risk of congenital adrenal hyperplasia (positive family history, member of a high-risk ethnic group), ES suggests this screening even if serum total and free testosterone are normal. (2|⊕⊕ ) ➤ ES suggests against testing for elevated androgen levels in eumenorrheic women with unwanted local hair growth (i.e., in the absence of an abnormal hirsutism score) because of the low likelihood of identifying a medical disorder that would change management or outcome. (2|⊕⊕ ) Diagnosis

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Hirsutism